Intelligent Bio Solutions Inc
NASDAQ:INBS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mackenzie Realty Capital Inc
OTC:MKZR
|
US |
|
Wee-Cig International Corp
OTC:WCIG
|
US |
|
Kyushu Electric Power Co Inc
TSE:9508
|
JP |
|
Xenetic Biosciences Inc
NASDAQ:XBIO
|
US |
|
Qingdao Vland Biotech INC
SSE:603739
|
CN |
|
T
|
Tri Viet Asset Management Corporation JSC
VN:TVC
|
VN |
|
G
|
Gogoro Inc
NASDAQ:GGR
|
TW |
|
R
|
Rex Trueform Group Ltd
JSE:RTO
|
ZA |
|
Lycopodium Ltd
ASX:LYL
|
AU |
Intelligent Bio Solutions Inc
Research & Development
Intelligent Bio Solutions Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Intelligent Bio Solutions Inc
NASDAQ:INBS
|
Research & Development
-$2.4m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$2.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Research & Development
-$1.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-11%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-21%
|
|
Intelligent Bio Solutions Inc
Glance View
GBS, Inc. operates as a biosensor diagnostic technology company. The company is headquartered in New York City, New York and currently employs 12 full-time employees. The company went IPO on 2020-12-23. The firm is developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. The firm's Intelligent Bio Solutions is a biosensor platform, which is engaged in developing and launching diagnostic tests urgently needed to help people living with chronic diseases. The firm's subsidiary Intelligent Fingerprinting is engaged in the advancement of portable drugs of abuse testing through the analysis of fingerprint sweat. The test is non-invasive, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The firm also offers laboratory confirmation services. The system has applications within many sectors in safety-critical industries such as construction, transport and logistics firms, drug treatment organizations, as well as the United Kingdom (UK) coroners.
See Also
What is Intelligent Bio Solutions Inc's Research & Development?
Research & Development
-2.4m
USD
Based on the financial report for Jun 30, 2025, Intelligent Bio Solutions Inc's Research & Development amounts to -2.4m USD.
What is Intelligent Bio Solutions Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-32%
Over the last year, the Research & Development growth was -43%. The average annual Research & Development growth rates for Intelligent Bio Solutions Inc have been 15% over the past three years , -32% over the past five years .
